{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:11:24Z","timestamp":1792746684686,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.euf.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:39:35Z","timestamp":1783633175000},"page":"695-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic Treatment"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4238-6584","authenticated-orcid":false,"given":"Benedikt","family":"Hoeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Mazzucato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tennstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Ekrutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Preisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bud\u00e4us","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Tilki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Steuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2026.05.002_b0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.juro.2006.08.057","article-title":"Changing nature of high risk patients undergoing radical prostatectomy","volume":"177","author":"Kane","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2026.05.002_b0010","unstructured":"Cornford P, Tilik D. EAU - EANM - ESTRO - ESUR - ISUP - SIOG guidelines on prostate cancer Edn. presented at the EAU Annual Congress Madrid 2025. ISBN 978-94-92671-29-5 [Internet]. EAU Guidelines Office. Arnhem, The Netherlands, http:\/\/uroweb.org\/guidelines\/compilations-of-all-guidelines\/."},{"key":"10.1016\/j.euf.2026.05.002_b0015","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: prostate cancer. version 2.2026. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"key":"10.1016\/j.euf.2026.05.002_b0020","doi-asserted-by":"crossref","first-page":"830.e17","DOI":"10.1016\/j.urolonc.2021.04.031","article-title":"Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume center","volume":"39","author":"W\u00fcrnschimmel","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2026.05.002_b0025","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006019","article-title":"Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer","volume":"2006","author":"Kumar","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euf.2026.05.002_b0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/cancers17010099","article-title":"Current status of neoadjuvant treatment before surgery in high-risk localized prostate cancer","volume":"17","author":"G\u00f3mez Rivas","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.euf.2026.05.002_b0035","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1200\/JCO.2013.53.4578","article-title":"Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study","volume":"32","author":"Taplin","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2026.05.002_b0040","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/JU.0000000000001632","article-title":"Outcomes of post-neoadjuvant intense hormone therapy and surgery for high risk localized prostate cancer: results of a pooled analysis of contemporary clinical trials","volume":"205","author":"McKay","year":"2021","journal-title":"J Urol"},{"issue":"6_suppl","key":"10.1016\/j.euf.2026.05.002_b0045","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.6_suppl.TPS285","volume":"40","author":"Kibel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2026.05.002_b0050","doi-asserted-by":"crossref","unstructured":"Giesen A, Devos G, Tosco L, et al. Final results of the randomised Phase 2 trial of neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer (ARNEO). Eur Urol Oncol. In press. https:\/\/doi.org\/10.1016\/j.euo.2025.12.005.","DOI":"10.1016\/j.euo.2025.12.005"},{"key":"10.1016\/j.euf.2026.05.002_b0055","unstructured":"R Core Team. R: A language and environment for statistical computing [Internet]. R Foundationfor Statistical Computing. 2021. http:\/\/www.R-project.com\/. Accessed March 1, 2022."}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:30:26Z","timestamp":1790875826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456926000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2405456926000702"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2026.05.002","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic Treatment","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}